# Potential Efficacy and Safety of Using Adjunctive Ibuprofen for XDR-TB Tuberculosis

> **NCT02781909** · PHASE2 · COMPLETED · sponsor: **Fundació Institut Germans Trias i Pujol** · enrollment: 24 (actual)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** Ibuprofen
- **DRUG:** Standard of Care TB treatment

## Key facts

- **NCT ID:** NCT02781909
- **Lead sponsor:** Fundació Institut Germans Trias i Pujol
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02781909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02781909, "Potential Efficacy and Safety of Using Adjunctive Ibuprofen for XDR-TB Tuberculosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02781909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*